← FDA Drug Approvals (Drugs@FDA)

TAVABOROLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS US · Approved 2020-10-13

Drug application

FDA Application #
ANDA211848
Application type
Abbreviated New Drug Application (Generic)
Brand name
TAVABOROLE
Generic name
Tavaborole
Active ingredients
TAVABOROLE
Dosage form
SOLUTION
Route
TOPICAL
Marketing status
Discontinued
Sponsor
PADAGIS US
First approval
2020-10-13

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown